You have 9 free searches left this month | to do more

palbociclib

Palbociclib is a drug used to treat Breast Cancer, HER2/Neu Negative, Breast Neoplasms, and other conditions. Palbociclib is being actively studied in 131 studies and prior, has been studied in 26.

Top SponsorsTop SitesTop Investigators
PfizerDana-Farber Cancer InstituteGeoffrey Shapiro, MD, PhD
Dana-Farber Cancer InstituteWashington University School of MedicineErica Mayer, MD, MPH
National Cancer Institute (NCI)Beth Israel Deaconess Medical CenterYeon Hee Park
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
2021-07-22
Jul 22, 2021
W
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Palbociclib
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-12-01
Dec 1, 2021
U
Palbociclib and FES PET
Active, not recruiting
  • Breast Cancer
  • Palbociclib
  • +2 more
  • Groningen, Netherlands
    University Medical Center Groningen
2021-02-01
Feb 1, 2021
F
Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET
Active, not recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Shanghai, China
    Fudan University Shanghai Cancer Center
2021-09-13
Sep 13, 2021
F
Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • HER2-positive Breast Cancer
  • Palbociclib
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
2021-09-29
Sep 29, 2021
P
Demographics, Characteristics, Treatment Patterns and Clinical Outcomes of Palbociclib Treated Patients in Israel
Recruiting
  • Metastatic Breast Cancer
  • palbociclib
  • Herzliya Pituach, Israel
    Pfizer Pharmaceuticals Israel Ltd.
2021-03-19
Mar 19, 2021
A
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
Recruiting
  • Metastatic Breast Cancer
  • +4 more
  • Palbociclib
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-07-20
Jul 20, 2021
M
Palbociclib In Progressive Brain Metastases
Recruiting
  • Metastatic Malignant Neoplasm to Brain
  • Palbociclib
  • Boston, Massachusetts
  • +1 more
2021-10-25
Oct 25, 2021
A
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
Not yet recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Timisoara, Timiș, Romania
    Asociatia Oncohelp - Centrul de Oncologie Oncohelp
2021-11-16
Nov 16, 2021
M
Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma
Recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Palbociclib
  • +2 more
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
2020-09-06
Sep 6, 2020
R
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Not yet recruiting
  • Colorectal Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-10-22
Oct 22, 2021
U
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-10-05
Oct 5, 2021
H
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
Recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • +2 more
  • Johannesburg, South Africa
    Wits Oncology center
2021-07-22
Jul 22, 2021
N
Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)
Active, not recruiting
  • Advanced Lymphoma
  • +4 more
  • Palbociclib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
2021-07-08
Jul 8, 2021
T
Palbociclib in Combination With Chemotherapy in Pediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (RELPALL2)
Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • +2 more
  • Palbociclib
  • +3 more
  • Stanford, California
    Lucile Packard Children's Hospital Stanford
2021-09-20
Sep 20, 2021
S
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
Recruiting
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +4 more
2021-01-08
Jan 8, 2021
D
Palbociclib With Everolimus + Exemestane In BC
Active, not recruiting
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Hormone Receptor (HR)-Positive Breast Cancer
  • Palbociclib
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-06-24
Jun 24, 2021
A
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    University of Pennsylvania
2021-07-26
Jul 26, 2021
D
A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer
Active, not recruiting
Has Results
  • Breast Cancer Stage IV
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-06-10
Jun 10, 2021
A
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
Recruiting
  • Female Breast Carcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-11-05
Nov 5, 2021
P
Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE
Recruiting
  • Melanoma
  • Metastasis
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
2021-01-19
Jan 19, 2021
J
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
Active, not recruiting
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2021-10-07
Oct 7, 2021
D
Palbociclib + Ganitumab In Ewing Sarcoma
Active, not recruiting
  • Ewing Sarcoma
  • Ewing's Sarcoma Recurrent
  • Boston, Massachusetts
  • +2 more
2021-11-15
Nov 15, 2021
S
Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • Refractory B Acute Lymphoblastic Leukemia
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2021-06-03
Jun 3, 2021
P
Swedish Ibrance Registries Insights (SIRI)
Recruiting
  • Malignant Neoplasm of Breast
  • palbociclib
  • Sollentuna, Sweden
    Pfizer AB
2021-03-29
Mar 29, 2021